US 6,887,996 B2Granted

Compounds and their use

AssigneeGuilford Pharmaceuticals Inc.

InventorsDana V. Ferraris, Jia-He Li, Vincent J. Kalish, Jie Zhang

Life of this patent

Estimating the term…

This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.

Dependent claims

A compound selected from the group consisting of:

Dependencies are inferred from the claim text.

A61K 31/55
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61K 31/551
Having seven-membered rings, e.g. azelastine, pentylenetetrazole: having two nitrogen atoms, e.g. dilazep
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…

From the US filing history. Foreign family members aren’t listed.

Loading patent…